Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study





Last update: 7:30 a.m. EDT Aug. 25, 2008


INDIANAPOLIS, Aug 25, 2008 /PRNewswire via COMTEX/ -- Data from a new study suggest that Cymbalta (duloxetine HCl) 60-120 mg once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) 24-hour average pain score, compared with placebo.(1) Results from the double-blind, 13-week, placebo-controlled study of 236 patients were presented today at the annual congress of the European Federation of Neurological Societies (EFNS) in Madrid, Spain.
http://www.marketwatch.com/news/story/patients-taking-cymbaltar-experienced-reduced/story.aspx?guid={8622C797-8B9C-4C1C-92F5-AC91522E3268}&dist=hppr